<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Role of methotrexate chronotherapy in collageninduced rheumatoid arthritis in rats</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-11-29">29 November 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Bad</roleName><forename type="first">U</forename><surname>Müller-Ladner</surname></persName>
						</author>
						<author>
							<persName><roleName>Bad</roleName><forename type="first">Nauheim</forename><forename type="middle">U</forename><surname>Lange</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nauheim</forename><forename type="middle">X</forename><surname>Wang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">•</forename><forename type="middle">X</forename><surname>Yan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Wang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Ge</surname></persName>
						</author>
						<author>
							<persName><forename type="first">•</forename><forename type="middle">Z</forename><surname>Li</surname></persName>
						</author>
						<author>
							<persName><forename type="first">X</forename><surname>Wang</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">Binzhou medical university hospital</orgName>
								<address>
									<settlement>Binzhou city</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Binzhou medical university hospital Binzhou city</orgName>
								<address>
									<addrLine>Shandong province</addrLine>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Role of methotrexate chronotherapy in collageninduced rheumatoid arthritis in rats</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-11-29">29 November 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">F00F7C4F0EAEF117AA7F16D154DE83E7</idno>
					<idno type="DOI">10.1007/s00393-016-0236-6</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:16+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Rheumatoid arthritis (RA) is an autoimmune disorder of unknown etiology.</s><s>In industrialized countries, rheumatoid arthritis affects 0.5-1.0% of adults, with 5-50 new cases per 100,000 annually <ref type="bibr" target="#b0">[1]</ref>.</s><s>RA not only induces disability that affects physical function, but also results in premature death.</s><s>Patients with RA have a poor life prognosis and a substantially shorter life expectancy compared to the general population <ref type="bibr" target="#b1">[2]</ref>.</s><s>Therefore, the development of an effective therapeutic strategy focusing on prevention and treatment of the disease, its complications, and associated disorders is imperative.</s></p><p><s>Methotrexate (MTX), which has been used for more than 40 years in the treatment of rheumatoid arthritis, has an antiinflammatory cytotoxic and immunosuppressive effect.</s><s>Currently, a small dose of intermittent medication is the standard treatment for RA, with proven efficacy and safety.</s><s>The therapeutic mechanisms of MTX in RA have yet to be fully elucidated.</s><s>The plasma halflife of MTX was 7 to 10 h, onset time 6 to 8 weeks, and the optimal therapeutic effect was seen after 2 to 3 months <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>.</s><s>MTX administrated twice weekly, according to the half-life of MTX, was better than once weekly.</s><s>However, the pilot study of Pandya has confirmed that the benefit was similar in either approach <ref type="bibr" target="#b4">[5]</ref>.</s><s>An uncontrolled trial conducted by To et al. suggested that MTX chronotherapy can improve RA symptoms compared to the current standard dosing methods <ref type="bibr" target="#b13">[14]</ref>.</s><s>Therefore, current clinical approaches involve oral or intramuscular injection of MTX once weekly and 12 h of continuous therapy twice or three times a week.</s><s>The first approach is widely accepted, owing to high patient compliance and flexibility.</s></p><p><s>In recent years, inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) have been observed in the blood and synovial fluid of humans, with excessive production of these cytokines implicated in the pathogenesis of RA <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s>The levels of inflammatory cytokines increased in the early morning in RA patients, with a clear circadian rhythm in the blood <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s><s>Chronotherapy is defined as the administration of medication based on biological rhythms in order to optimize therapeutic outcomes and/or control adverse effects.</s><s>RA chronotherapy has been researched basically and clinically with glucocorticoids <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>, MTX <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>, tacrolimus <ref type="bibr" target="#b14">[15]</ref>, and mizoribine <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>.</s><s>The results showed that selection of the optimal dosage associated with a circadian rhythm of RA symptoms resulted in an effective treatment for RA.</s></p><p><s>In view of these findings, we decided to investigate methotrexate chronotherapy using a collagen-induced arthritis (CIA) rat model immunized with bovine type II collagen.</s><s>In this study, serum IL-6 levels were measured at six different time points.</s><s>MTX was administered at two different dosing intervals based on these findings, and its efficacy and toxicity were evaluated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animals</head><p><s>Six-week-old, female Wister rats weighing 160 to 170 g each were purchased from the Experimental Animal Center of Shandong (Shandong, China).</s><s>The study was conducted at Bin Zhou (Shandong, China).</s><s>They were housed 6 in each cage under standardized light-dark cycle conditions (lights-on and lights-off at 07:00 and 19:00 h, respectively) at a room temperature of 24 ± 1 °C and a humidity of 60 ± 10% with free access to food and water.</s><s>Experiments were conducted after formal approval by the Institutional Ethical Committee for Research on Animals.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reagents</head><p><s>The reagents included bovine collagen type II (CII) and complete Freund's adjuvant (CFA; Chondrex, Washington, USA), as well as MTX (Shanghai Sine Pharmaceutical Co., Ltd., Shanghai, China).</s><s>Enzyme-linked immunosorbent assay (ELISA) kits of TNF-α, IL-6, and CRP (R&amp;D system, Minnesota, USA) were purchased.</s><s>All the other chemicals and biochemicals used were of the highest grade available.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Induction of collagen-induced arthritis</head><p><s>Bovine collagen type II (CII) was dissolved in 0.05 mol/L acetic acid at 2 mg/ml and emulsified in an equal volume of CFA.</s><s>Rats were immunized intracutaneously with 200 μl of the emulsion divided into four points along the dorsal spine symmetrically.</s><s>Seven days later, a similar amount of bovine CII emulsified into CFA was injected intracutaneously as a booster dose.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of arthritis</head><p><s>The severity of CIA was assessed using a scoring system <ref type="bibr" target="#b17">[18]</ref>.</s><s>The disease severity was recorded for each limb as follows: score 0, normal; 1, erythema and mild swelling confined to the midfoot (tarsals) or ankle joint; 2, erythema and mild swelling extending from the ankle to the midfoot; 3, erythema and moderate swelling extending from the ankle to the metatarsal joint; and 4, erythema and severe swelling of the ankle, foot, and digits.</s><s>The clinical arthritis score was defined as the sum of the scores of all four paws of each rat.</s><s>Evaluation was completed by two experimenters independently.</s><s>Final score included the average of the two scores.</s><s>Arthritis index (AI) represented the total joint score.</s><s>The model was successful when the AI was equal to or greater than 4.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Groups and treatment</head><p><s>Wistar rats were divided randomly into five groups (n = 8 per group): the 6 hours after the light was turned on (HALO) and the 18 HALO experimental groups, the qw positive controls, the PBS negative controls, and the normal control group.</s><s>MTX (1/7 mg/kg) was administered at 6 HALO when the IL-6 level started to decrease and at 18 HALO when the IL-6 level started to increase, once daily by gastric perfusion, separately from day 1 to day 56 after successful modeling.</s><s>In the qw (once a week) positive control group, MTX (1 mg/kg) was administered once weekly by gastric perfusion.</s><s>The PBS control and the normal groups were given an equal volume of phosphate buffer saline (PBS) simultaneously.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-6 level after initial immunization</head><p><s>IL-6 levels of the rats were measured on days 0, 7, 14, 21, 28, and 35 for signs of arthritis between days 1 and 36 after initial immunization.</s><s>Blood was drawn from the caudal vein of CIA rats (n = 5) on days 0, 7, 14, 21, 28, and 35 after initial immunization.</s><s>Serum was obtained by centrifugation at 3000 rev/min for 10 min and frozen at -80 °C until assay.</s><s>We measured IL-6 levels using an ELISA kit.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>24-hour rhythm in serum IL-6 levels</head><p><s>On day 21 after immunization, blood was collected at six different times (2, 6, 10, 14, 18, or 22 HALO) in normal (n = 5) or untreated CIA (n = 8) rats, and centrifuged immediately at 3000 rpm for 10 min.</s><s>Serum was obtained and stored at -20 °C until analyzed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Influence of MTX chronotherapy on arthritis score</head><p><s>The rats were assessed every 3 days for signs of arthritis between days 1 and 56 after immunization using the scoring system <ref type="bibr" target="#b17">[18]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement of serum TNF-α, IL-6, and CRP level</head><p><s>Blood was collected and serum was obtained by centrifugation at 3000 rpm for 10 min and stored at -80 °C prior to analysis.</s><s>Serums IL-6 levels were quantified by ELISA.</s><s>The same procedure was used to assay TNF-α and CRP with the cytokine-specific antibodies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histological analysis</head><p><s>On day 56, all rats were sacrificed via anesthesia after serum collection.</s><s>The ankle joints were removed from the rats for histological examination.</s><s>The joints were fixed in 10% phosphate-buffered formalin, decalcified in 10% EDTA for 30 days at 4 °C, and then embedded in paraffin.</s><s>Serial paraffin sections (5 mm thick) were stained with hematoxylin and eosin (H&amp;E).</s><s>Pathological sections were examined and graded for inflammation, pannus formation, cartilage damage, and bone resorption microscopically, and scored using histopathology scoring criteria <ref type="bibr" target="#b18">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Leukocyte count analysis</head><p><s>On day 56, blood samples were drawn from the inferior vena cava and leukocyte counts of the rats were performed immediately after blood drawing.</s><s>Aim.</s><s>To explore the circadian rhythm of serum interleukin (IL)-6 in collageninduced arthritis (CIA) rats and compare the safety and effectiveness of methotrexate (MTX) administered traditionally and via chronotherapy.</s><s>Methods.</s><s>CIA rat models were immunized with bovine type II collagen.</s><s>Serum IL-6 levels in normal and CIA rats were measured at 2, 6, 10, 14, 18, or 22 h after the light was turned on (HALO).</s><s>MTX was administered to 6 HALO/18 HALO experimental groups of Wistar rats once daily according to the IL-6 rhythm.</s><s>The control groups (positive, negative, and normal) were given MTX or an equal volume of phosphate buffered saline (PBS) once a week simultaneously.</s><s>Arthritis score, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and C reactive protein (CRP) levels in the serum were measured by enzyme-linked immunosorbent assay (ELISA).</s><s>Histological changes in the ankle joint were analyzed.</s><s>Results.</s><s>After 6 weeks of treatment, arthritis scores in the experimental group were lower than in the control group.</s><s>The expression of TNF-α, IL-6, and CRP was lower in the 18 HALO group than in the control or 6 HALO groups.</s><s>Histopathology scores in the experimental groups were lower than in the control group (p &lt; 0.05).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion.</head><p><s>The plasma IL-6 levels in CIA rats were higher than in normal rats and showed significant circadian rhythm.</s><s>Daily administration of MTX is more potent than weekly administration.</s><s>The therapeutic index of rheumatoid arthritis (RA) may be improved with MTX therapy based on the IL-6 circadian rhythm.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Keywords</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>The results were analyzed using a statistical program SPSS/PC+, version 13.0 (SPSS Inc, Chicago, IL, USA).</s><s>Oneway analysis of variance (ANOVA) and repeated-measures ANOVA were used to determine the statistically significant differences between the various experimental groups.</s><s>Differences between groups were determined using Scheffe's or Fisher's protected least significant difference test.</s><s>Data are expressed as means ± standard deviation (SD) and p &lt; 0.05 was considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Increased IL-6 levels after immunization and circadian rhythm of serum IL-6 levels</head><p><s>The IL-6 levels started to increase after immunizationandpeakedonday21; they then decreased and eventually returned to normal levels on day 35 (.</s><s>Fig. <ref type="figure" target="#fig_0">1a</ref>).</s><s>Serum IL-6 concentrations in collageninduced arthritic rats were higher than in normal rats on day 21.</s><s>IL-6 levels showed significant circadian rhythms, with higher levels in 6 HALO and lower levels in 18 HALO CIA rats (.</s><s>Fig. <ref type="figure" target="#fig_0">1b</ref>).</s><s>Serum IL-6 showed no circadian rhythm in normal rats (p &gt; 0.05).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect of MTX chronotherapy on arthritis score and pathology changes</head><p><s>In the study, the arthritis scores were assessed ineachgroup, whicheachincluded 8 rats.</s><s>In the normal group, there was no joint swelling during the whole experi-Fig. <ref type="figure">2</ref> 8 Influence of methotrexate chronotherapy on arthritis score and ankle joint histopathological changes.Data represent the mean ± standard deviation (n = 8).</s><s>The arthritis scores were assessed in each group (a) and suppressed peak arthritic severity compared with the once a week (qw) and blank control group was seen on day 56 (b).</s><s>c Histopathology score comparisons between groups on day 56.</s><s>Histopathology: d normal group, e collagen-induced arthritis rats, f phosphate-buffered saline (PBS) control group, g qw control group, h 6 hours after the light was turned on (HALO) experimental group, i 18 HALO experimental group ment and the arthritis score was zero at each time point.</s><s>Rats on days 7-10 after initial immunization showed congestion and edema of ankle joints.</s><s>On days 10 to 16 after initial immunization, the ankles showed swelling and hyperemia, which increased by day 21, followed by a gradual decline in joint swelling (.</s><s>Fig. <ref type="figure">2a</ref>).</s><s>MTX administrated once weekly or once daily decreased the arthritis score significantly (.</s><s>Fig. <ref type="figure">2a</ref>).</s><s>On day 56, the arthritic severity in the 6 HALO/18 HALO experimental groups was markedly decreased compared to the qw and PBS control groups on day 56 (p &lt; 0.05).</s><s>The Arthritis score in the 18 HALO experimen-tal group was obviously decreased compared to the 6 HALO experimental group (p &lt; 0.05; .</s><s>Fig. <ref type="figure">2b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect of MTX dosing time on pathology changes</head><p><s>After MTX treatment, histopathology scores were reduced (p &lt; 0.05) and the histopathology scores were lower in 6 am and 18 HALO experimental groups than in the qw positive control group (p &lt; 0.05; .</s><s>Fig. <ref type="figure">2c</ref>).</s><s>The effect of MTX dosing time on ankle joint histopathological changes varied.</s><s>The normal group of rats showed normal articular cartilage and absence of damage in the synovium (.</s><s>Fig. <ref type="figure">2d</ref>).</s><s>The CIA rats showed marked infiltration of inflammatory cells (.</s><s>Fig. <ref type="figure">2e</ref>).</s><s>The PBS control group showed marked infiltration of inflammatory cells and synovial hyperplasia, and the mean histopathology score was 11.7 ± 2.6 (.</s><s>Fig. <ref type="figure">2f</ref>).</s><s>The qw positive control group was treated with MTX once a week and the mean histopathology scores were 9.07 ± 1.98 (.</s><s>Fig. <ref type="figure">2g</ref>).</s><s>The mean histopathology score in the 6 HALO experimental group was 7.43 ± 1.28 (.</s><s>Fig. <ref type="figure">2h</ref>) while this was 6.64 ± 1.27 in the 18 HALO experimental group (.</s><s>Fig. <ref type="figure">2i</ref>).</s><s>Effect of MTX dosing time on TNFα, IL-6, and CRP levels MTX was administered every day at 6 HALO or 18 HALO based on the circadian rhythm of IL-6 level.</s><s>The OD values of TNF-α, IL-6, and CRP in the 18 HALO experimental group were markedly decreased compared with the PBS and qw control groups (p &lt; 0.05; .</s><s>Fig. <ref type="figure" target="#fig_2">3</ref>).</s><s>The OD values of IL-6 (.</s><s>Fig. <ref type="figure" target="#fig_2">3b</ref>) and CRP (.</s><s>Fig. <ref type="figure" target="#fig_2">3c</ref>) in the 18 HALO group were markedly decreased compared with those of the 6 HALO group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect of MTX dosing time on myelosuppression</head><p><s>After MTX treatment, leukocyte counts were lower in the 6 HALO and 18 HALO experimental groups than in controls (.</s><s>Fig. <ref type="figure">4</ref>, p &lt; 0.05), but they were still within the normal range.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Rheumatoid arthritis (RA) is a chronic progressive inflammatory disease with massive infiltration of inflammatory cells in the synovium of multiple joints.</s><s>Monocytes, T and B lymphocytes, and fibroblasts produce inflammatory cytokines including IL-6, TNF, and other proinflammatory cytokines.</s><s>These cy-tokines contribute to RA pathogenesis and were reduced rhythmically corresponding to major symptoms, such as pain, inflammation, and stiffness <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21]</ref>.</s></p><p><s>The CIA rat model mimics certain features of RA <ref type="bibr" target="#b21">[22]</ref>.</s><s>It is internationally recognized for the study of RA.</s><s>In our study, we have measured IL-6 levels (.</s><s>Fig. <ref type="figure" target="#fig_0">1a</ref>) of rats after immunization.</s><s>We found that the IL-6 level was relatively high on day 21.</s><s>Therefore, in a later study, we measured the levels of IL-6 at six different time points on day 21.</s><s>We found that the level of IL-6 showed a clear 24-hour rhythm, with higher levels at 6 HALO and lower levels at 18 HALO in the CIA rats (.</s><s>Fig. <ref type="figure" target="#fig_0">1b</ref>).</s></p><p><s>RA is characterized by synovial hyperplasia, pannus formation, and cartilage and bone destruction in the joint.</s><s>In our study, we found that 1 week after immunization, the skin of the foot joints in rats was flushed, with mild swelling.</s><s>After 2 weeks, most of the rat ankle joint was swollen, with shiny skin and limited joint mobility.</s><s>After 3 weeks, skin ulcers were found in some rats, and joint swelling and deformation were found after 5 to 6 weeks.</s><s>In our study, we assessed the arthritis score of the rats (.</s><s>Fig. <ref type="figure">2a</ref>) and compared the arthritis index of each group on day 56 (.</s><s>Fig. <ref type="figure">2b</ref>).</s><s>At the end of the experiment, the rats were sacrificed and the ankle joints were removed for histological examination and histopathological evaluation by H&amp;E staining.</s><s>The ankle joints, cartilage, and joint space in normal rats were normal.</s><s>The knee joints of the CIA rats displayed notable synovial hyperplasia, inflammatory cell filtration, and partial bone destruction (.</s><s>Fig. <ref type="figure">2d-i</ref>).</s><s>The scores of the experimental groups were significantly lower than that of the control group (.</s><s>Fig. <ref type="figure">2c</ref>).</s><s>Studies have shown that treatment based on circadian rhythms might delay the progression of pathology.</s></p><p><s>TNF-α plays an important role in the pathogenesis of RA.</s><s>It mediates inflammatory cell infiltration, cartilage destruction, and systemic inflammation.</s><s>It also induces the synthesis of proinflammatory cytokines (such as IL-1 and IL-6) and chemokines, and activates macrophages, which in turn perpetuate the inflammation in autoimmune pathology <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s>Plasma TNF-α and TNF-α mRNA expression showed a clear circadian rhythm, with peaks 2 h after the light was turned on in MRL/lpr mice, leading to an excellent outcome when MTX was administered under increased cytokine conditions <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>.</s><s>Some researchers have postulated that MTX reduces plasma TNF-α level by suppressing transcriptional activity rather than by suppressing lymphocyte proliferation <ref type="bibr" target="#b13">[14]</ref>.</s><s>In our study, the levels of plasma TNF-α were measured.</s><s>We found that Fig. <ref type="bibr" target="#b3">4</ref> 8 Effect of methotrexate dosing time on leukocyte counts.</s><s>On day 56, blood samples were drawn from the inferior vena cava and leukocyte counts of the rats were performed immediately after blood drawing.</s><s>Values represent the mean ± standard deviation.</s><s>Leukocyte counts were lower in 6 hours after the light was turned on (HALO) and 18 HALO experimental groups than in controls (p &lt; 0.05), but are still within the normal range.</s><s>PBS phosphate-buffered saline, qw once a week the value of TNF-α in the 18 HALO experimental group was markedly decreased compared with the PBS and qw control groups (p &lt; 0.05; .</s><s>Fig. <ref type="figure" target="#fig_2">3a</ref>).</s><s>These results indicate that MTX once daily is superior to once weekly.</s></p><p><s>IL-6 is a key proinflammatory cytokine in RA.</s><s>It mediates osteoclast activation and fibroblast synovial cell activation, thus contributing to synovial pannus formation, joint destruction, and bone and cartilage breakdown.</s><s>In our study, we demonstrated higher plasma IL-6 levels in CIA rats than in normal rats at almost every sampling time, with a significant circadian rhythm indicating higher levels during the light phase and lower levels in the dark phase (.</s><s>Fig. <ref type="figure" target="#fig_0">1b</ref>).</s><s>Based on the circadian rhythm, we administered MTX once daily according to a chronotherapy schedule, in which MTX was givenat6 HALO or 18 HALO without altering the dosage.</s><s>We assessed arthritis score; production of TNF-α, IL-6, and CRP in serum; and histological changes of ankle joints.</s><s>In rats, the arthritis score was significantly lower in the 18 HALO experimental group than in the control and 6 HALO experimental groups on day 24.</s><s>On day 56, the 18 HALO experimental group treatment significantly inhibited the increase of arthritis score compared to the control and 6 HALO ex-perimental groups in rats (.</s><s>Fig. <ref type="figure" target="#fig_2">3b</ref>), and showed a clear improvement in inflammatory cytokines.</s><s>These results indicate that MTX administered once daily was better than once weekly, and that MTX chronotherapy was effective in treating CIA rats.</s></p><p><s>CRP is a marker of inflammatory responses.</s><s>Plasma CRP levels showed a circadian rhythm, with a peak in the early morning in RA patients that matched the rhythms of pain and stiffness <ref type="bibr" target="#b24">[25]</ref>.</s><s>Studies have confirmed that CRP levels showed a clear circadian rhythm with a peak at 22 HALO, in accordance with those seen in CIA and MRL/lpr mice <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref>.</s><s>In our study, after 8 weeks of treatment, the CRP level in the 18 HALO experimental group showed a clear decrease compared to the qw group (.</s><s>Fig. <ref type="figure" target="#fig_2">3c</ref>).</s><s>Our study suggests that MTX once daily has an advantage over once weekly in terms of efficacy, and thus the currently used once-weekly regimen is good enough until alternate dosing schedules are evaluated in a large double-blind, randomized, controlled multicentric trial.</s></p><p><s>Leukocyte counts increase <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b26">27]</ref> in most RA patients and induce an inflammatory response.</s><s>RA symptoms markedly improved following leukocytapheresis <ref type="bibr" target="#b27">[28]</ref>.</s><s>Leukocyte counts were measured in MRL/lpr mice and were found to be significantly increased after RA onset.</s><s>Circadian variations in the toxicity of MTX have also been demonstrated in rats, with maximum toxicity occurring after dosage at 06:00 h and minimum toxicity after dosage at midnight.</s><s>Administration at the other two time points, 12.00 h and 18.00 h, gave intermediate results <ref type="bibr" target="#b28">[29]</ref>.</s><s>A common side effect of MTX is leucopenia in RA patients.</s><s>In this study, we found that leukocyte counts decreased in 6 HALO and 18 HALO experimental groups, but increased in the qw positive control group (.</s><s>Fig. <ref type="figure">4</ref>).</s><s>Inhibition of increased leukocyte counts may be one of the options available for treatment of RA.</s><s>In the current study, we also found a slow increase in body weight of rats following treatment, which may account for the adverse gastrointestinal effects of MTX.</s></p><p><s>The role of proinflammatory cytokines, including TNF-α and IL-6, in the pathogenesis of RA has led to the development of biological disease modifying antirheumatic drugs (bDMARDs), which specifically inhibit these cytokines.</s><s>Selecting the optimal therapeutic dosage based on circadian rhythms of inflammation and cytokine response in RA may result in successful outcomes.</s></p><p><s>It has been reported in previous studies that CIA mice administered MTX in the resting phase showed a larger area under the plasma concentration-time curve of MTX than mice administered MTX in the active phase <ref type="bibr" target="#b12">[13]</ref>, and that the daily variations in the pharmacokinetics of MTX were not related to the dosingtime dependency of MTX efficacy <ref type="bibr" target="#b13">[14]</ref>.</s><s>From the results of our studies and the 24-hour cycles of cytokines in RA patients <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b9">10]</ref>, it is thought that MTX has a significant dosing time-dependent antiinflammatory action and that this effect may be due to the 24-hour rhythms of cytokine levels rather than the pharmacokinetics of MTX.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>This study indicated that plasma IL-6 levels in CIA rats were higher than in normal rats and showed a significant circadian rhythm.</s><s>The RA therapeutic score may be improved by administering MTX once daily, according to the circadian rhythm of IL-6.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 9</head><label>1</label><figDesc><div><p><s>Fig. 1 9 Interleukin 6 (IL-6) levels of rats after initial immunization.</s><s>The IL-6 levels in collagen-induced arthritis (CIA) rats increased after immunization and peaked on day 21 (a).</s><s>Circadian rhythms of plasma IL-6 in normal (n = 5) and CIA (n = 8) rats (b).</s><s>Each value represents the mean ± standard deviation.</s><s>(*p &lt; 0.05 compared with the normal group)</s></p></div></figDesc><graphic coords="2,51.02,69.41,396.96,137.76" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Cytokine • Circadian rhythm • Inflammatory • Treatment • Histopathyology Bedeutung der Methotrexat-Chronotherapie bei kollageninduzierter rheumatoider Arthritis von Ratten Zusammenfassung Ziel der Arbeit.</s><s>Ziel war es, den zirkadianen Rhythmus von Interleukin-6 (IL-6) im Serum von Ratten mit kollageninduzierter Arthritis (CIA) zu untersuchen sowie die Sicherheit und Wirksamkeit von Methotrexat (MTX) bei herkömmlicher Gabe und per Chronotherapie zu vergleichen.</s><s>Methoden.</s><s>Als Modell der CI dienende Ratten wurden mit Kollagen vom bovinen Typ II immunisiert.</s><s>Die Serumspiegel von IL-6 wurden bei normalen und CIA-Ratten 2, 6, 10, 14, 18 oder 22 h nach Einschalten des Lichts (HALO) gemessen.</s><s>Den Wistar-Ratten in den Versuchsgruppen 6 HALO/18 HALO wurde einmal täglich MTX entsprechend dem IL-6-Rhythmus verabreicht.</s><s>Gleichzeitig wurde den Kontrollgruppen (positiv, negativ und normal) einmal pro Woche MTX oder das gleiche Volumen phosphatgepufferter Salzlösung ("phosphate buffered saline", PBS) gegeben.</s><s>Ermittelt wurden der Arthritis-Score sowie die Serumspiegel von Tumornekrosefaktoralpha (TNF-α), IL-6 und C-reaktivem Protein (CRP) anhand der Messung mittels ELISA-Test ("enzyme-linked immunosorbent assay").</s><s>Außerdem wurden histologische Veränderungen im Fußgelenk untersucht.</s><s>Ergebnisse.</s><s>Nach 6-wöchiger Therapie waren die Arthritis-Scores in der Versuchsgruppe niedriger als in der Kontrollgruppe.</s><s>Die Expression von TNF-α, IL-6 und CRP war in der Gruppe 18 HALO geringer ausgeprägt als in der Kontrollgruppe und der Gruppe 6 HALO.</s><s>Darüber hinaus waren die histopa-thologischen Werte in den Versuchsgruppen niedriger als in der Kontrollgruppe (p &lt; 0,05).</s><s>Schlussfolgerung.</s><s>Die Werte für IL-6 im Plasma waren bei CIA-Ratten höher als bei normalen Ratten und wiesen einen signifikant ausgeprägten zirkadianen Rhythmus auf.</s><s>Dabei stellte sich die tägliche Gabe von MTX als wirksamer heraus denn die wöchentliche Verabreichung.</s><s>Der therapeutische Index bei rheumatoider Arthritis (RA) lässt sich möglicherweise mit einer MTX-Therapie verbessern, die auf dem zirkadianen Rhythmus von IL-6 basiert.</s><s>Schlüsselwörter Cytokin • Biorhythmus • Entzündung • Behandlung • Histopathologie</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 8</head><label>3</label><figDesc><div><p><s>Fig. 3 8 Effect of methotrexate dosing time on tumor necrosis factor-α (TNF-α), interleukin (IL-6), and C reactive protein (CRP) levels.</s><s>The (optical density) OD value of TNF-α, IL-6, and CRP in the 18 hours after the light was turned on (HALO) experimental group was markedly decreased compared with the phosphate-buffered saline (PBS) and once a week (qw) control groups (p &lt; 0.05; a-c).</s><s>The OD values of IL-6 (b) and CRP (c ) in the 18 HALO group were markedly decreased compared with those of the 6 HALO group</s></p></div></figDesc><graphic coords="5,51.02,69.77,493.20,169.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="4,51.02,69.65,493.20,390.48" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="7,391.20,36.48,153.12,700.20" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Zeitschrift für Rheumatologie 3 • 2018249   </note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Zeitschrift für Rheumatologie 3 • 2018251   </note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Zeitschrift für Rheumatologie 3 • 2018253   </note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Conflict of interest. X. Wang, X. Yan, F. Wang, F. Ge, and Z. Li declare that they have no competing interests.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Acknowledgements.</s><s>This study was funded by the Shandong Province Medical and Health Science and Technology Development Plan (grant number 2014WS0489).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Compliance with ethical guidelines</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.</s></p><p><s>Open Access.</s><s>Thisarticleisdistributedundertheterms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/ 4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fachnachrichten Ärzte lernen, besser über Resistenzgefahr aufzuklären</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Im Kampf gegen Antibiotika-Resistenzen ist ein</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Huizinga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">376</biblScope>
			<biblScope unit="page" from="1094" to="1108" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>Rheumatoid arthritis</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Methotrexateandmortalityinpatientswith rheumatoid arthritis: a prospective study</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hernán</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Seeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wolfe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="page" from="1173" to="1177" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Understanding the Mechanism of action of methotrexate: implications for the treatment of rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Cronstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bull NYU Hosp Jt Dis</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="168" to="173" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Methotrexate modulates the kinetics of adenosine in humans in vivo</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Riksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Barrera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Van Den Broek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="465" to="470" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Methotrexate twice weekly vs once weekly in rheumatoid arthritis: a pilot double-blind, controlled study</title>
		<author>
			<persName><forename type="first">Aggarwala</forename><surname>Pandyas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Misrar</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rheumatol Int</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1" to="4" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Role of cytokines in rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Maini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="397" to="440" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Cytokine networkstowards new therapies for rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Mcinnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Liew</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Clin Pract Rheumatol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="31" to="39" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Circadian relationships between interleukin (IL)-6 and hypothalamicpituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Crofford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Kalogeras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mastorakos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1279" to="1283" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Circadian rhythms in RA</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cutolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Seriolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Craviotto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="593" to="596" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Overnight variations in cortisol, interleukin 6, tumor necrosis factor-α and other cytokines in people with rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Kirwan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Jessop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Hunt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="63" to="68" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The timing of glucocorticoid administration in rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">Gudbjörnssonb</forename><surname>Arvidsonng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hällgrenr</forename><surname>Larssona</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="27" to="31" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomized controlled trial</title>
		<author>
			<persName><forename type="first">F</forename><surname>Buttgereit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Doering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schaeffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sierakowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gromnica-Ihle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<biblScope unit="page" from="205" to="214" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Therapeutic index of methotrexate depends on circadian cycling of tumour necrosis factor-alpha in collagen-induced arthritic rats and mice</title>
		<author>
			<persName><forename type="first">H</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Irie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomonari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kitahara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sasaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharm Pharmacol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1333" to="1338" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Methotrexate chronotherapy is effective against rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">H</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshimatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomonari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsurumoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tsuji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chronobiol Int</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="267" to="274" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Dosing time-dependency of the arthritis-inhibiting effect of tacrolimus in mice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Obayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomonari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshimatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fukuyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ieiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Higuchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="264" to="273" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Chronotoxicity of mizoribine under repeated administration in the rat</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Uchida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fujimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transplant Proc</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="2765" to="2766" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Chronopharmacology of mizorribine in collageninducedarthritisrats</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kanasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomonari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>To</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JPharmacolSci</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="112" to="120" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Lactobacillus GG bactofia ameliorate arthritis in Lewis rats</title>
		<author>
			<persName><forename type="first">E</forename><surname>Baharav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Halpern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Weinberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="1964" to="1969" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Effects of interleukin-1 receptor antagonist in a slow-release hylan vehicle on rat type II collagen</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bendele</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharm Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1557" to="1561" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Exogenous and endogenous glucocorticoids in rheumatic diseases</title>
		<author>
			<persName><forename type="first">F</forename><surname>Buttgereit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Burmester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Starub</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Straub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cutolo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="399" to="408" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Autoimmunity to type II collagen an experimental model of arthritis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Trentham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Tuwnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="857" to="868" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Prolonged TNF primes firoblast-like synoviocytes in a gene-specifi manner by altering chromatin</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sohc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Qiao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="86" to="95" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Interleukin-18 induces IL-8 and IL-1via TNF production from non-CD14+humanbloodmononuclearcells</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Puren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fantuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JClin Invest</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="711" to="721" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Circadian rhythm of C-reactive protein in patients with rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Herold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gunther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Clin Biol Res</title>
		<imprint>
			<biblScope unit="volume">227</biblScope>
			<biblScope unit="page" from="271" to="279" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Visualization and in situ analysis of leukocyte trafficking into the ankle joint in a systemic murine model of rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Gál</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bajnok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Szántó</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sarraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Glant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mikecz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="3269" to="3278" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Kaneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Leger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kuliopulos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="page" from="4416" to="4424" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Multicenter study of leukocytapheresis in rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ueki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Tsuda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Rheumatol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="810" to="816" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The effect of timing of a single injection on the toxicity of methotrexate in the rat</title>
		<author>
			<persName><forename type="first">J</forename><surname>English</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Aherne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Marks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Chemother Pharmacol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="114" to="117" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
